Bora CDMO Bora CDMO

X

Find Dalcetrapib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Dalcetrapib
Also known as: 211513-37-0, Jtt-705, Dalcetrapib (jtt-705, ro4607381), Ro4607381, Ro-4607381, Jtt 705
Molecular Formula
C23H35NO2S
Molecular Weight
389.6  g/mol
InChI Key
YZQLWPMZQVHJED-UHFFFAOYSA-N
FDA UNII
3D050LIQ3H

Dalcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrapib, and raises functional HDL by a different mechanism.
1 2D Structure

Dalcetrapib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate
2.1.2 InChI
InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)
2.1.3 InChI Key
YZQLWPMZQVHJED-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C
2.2 Other Identifiers
2.2.1 UNII
3D050LIQ3H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Jtt 705

2. Jtt-705

3. Jtt705

4. Ro-4607381

5. Ro4607381

6. S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate

2.3.2 Depositor-Supplied Synonyms

1. 211513-37-0

2. Jtt-705

3. Dalcetrapib (jtt-705, Ro4607381)

4. Ro4607381

5. Ro-4607381

6. Jtt 705

7. Jtt705

8. S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate

9. 2-methylpropanethioic Acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] Ester

10. 3d050liq3h

11. Chembl313006

12. S-(2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl) 2-methylpropanethioate

13. S-2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl 2-methylpropanethioate

14. S-[2-({[1-(2-ethylbutyl)cyclohexyl]carbonyl}amino)phenyl] 2-methylpropanethioate

15. Thioisobutyric Acid S-(2-{[1-(2-ethyl-butyl)-cyclohexanecarbonyl]-amino}-phenyl) Ester

16. Rg-1658

17. Dalcetrapib [mi]

18. Dalcetrapib [inn]

19. Dalcetrapib (usan/inn)

20. Dalcetrapib [usan:inn]

21. Dalcetrapib [usan]

22. Dalcetrapib (jtt-705)

23. Unii-3d050liq3h

24. Dalcetrapib [who-dd]

25. Schembl528622

26. Chebi:95001

27. Dalcetrapib, >=97% (hplc)

28. Dtxsid70943475

29. Ex-a092

30. Bcpp000268

31. Hms3656f06

32. Amy21305

33. Zinc3976476

34. Bdbm50092197

35. Mfcd06407886

36. S2772

37. Dalcetrapib Pound Jtt-705 Pound(c)

38. Akos015966940

39. Bcp9000580

40. Ccg-264995

41. Cs-0916

42. Db12181

43. Pb12356

44. S-(2-(1-(2-ethylbutyl)cyclohexane-1-carboxamido)phenyl) 2-methylpropanethioate

45. Ncgc00386198-05

46. Ac-27462

47. As-55940

48. Hy-14950

49. Dalcetrapib (jtt-705; Ro-4607381)

50. Ft-0769704

51. Sw219843-1

52. A25148

53. D09708

54. J-510086

55. Q5210285

56. Brd-k18849474-001-01-0

57. Jtt-705;s-2-(2-ethylbutyl)-2-formamidocyclohexyl 2-methyl-2-phenylpropanethioate

58. S-[2-[1-(2-ethylbutyl)cyclohexanecarbonylamino]-phenyl] 2-methylthiopropionate

59. Propanethioic Acid, 2-methyl-, S-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino)phenyl) Ester

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 389.6 g/mol
Molecular Formula C23H35NO2S
XLogP37.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count9
Exact Mass389.23885053 g/mol
Monoisotopic Mass389.23885053 g/mol
Topological Polar Surface Area71.5 Ų
Heavy Atom Count27
Formal Charge0
Complexity481
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Lipoprotein deficiency


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anticholesteremic Agents

Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY